Bukwang Pharmaceutical

Bukwang Pharmaceutical is a South Korean company researching, manufacturing, and distributing its own or its subsidiaries' prescription and over-the-counter (OTC) drugs as well as licensed drugs from worldwide partners.

The company reinvests more than 18% of its sales into product research and development. Its subsidiaries include Bukwang Medica (100% stake) and Contera Pharma (94.38% stake). The company has also invested in foreign companies, such as their $25 million investment in Melior Pharmaceuticals, an American company developing tolimidone (for treatment of type 2 diabetes and nonalcoholic steatohepatitis) and mesocarb (treatment of Parkinson’s dyskninesias and sleep disorders).

Bukwang Pharmaceutical

Company listings

KRX: 003000

Other Companies in Pharmaceuticals, Biotechnology and Life Sciences

Celltrion is a South Korean biopharmaceutical company manufacturing, distributing, and selling medication and treatments for autoimmune diseases and cancers.

ChongKunDang is a South Korean pharmaceutical company manufacturing and distributing prescription and over-the-counter medication, health supplements, and consumer health and household products suc

Daewoong Pharmaceutical is a company manufacturing and distributing pharmaceutical products.

Dong-A ST is a pharmaceutical company manufacturing prescription, over-the-counter medication, and test kits for various diseases and infections; and importing medical devices.

GC Pharma (formerly Green Cross Corporation) is a company manufacturing and distributing pharmaceutical products.